Published 13:52 IST, February 9th 2024
Moderna-backed Metagenomi cuts US IPO valuation target to $563 mn
Moderna-backed Metagenomi cuts US IPO valuation target to $563 mn
Moderna-backed Metagenomi cuts US IPO valuation target to $563 mn | Image:
Metagenomi
Advertisement
13:52 IST, February 9th 2024